Literature DB >> 8606125

Experimental Yersinia infection of human synovial cells: persistence of live bacteria and generation of bacterial antigen deposits including "ghosts," nucleic acid-free bacterial rods.

H I Huppertz1, J Heesemann.   

Abstract

Yersinia enterocolitica O:3 was maintained in primary cultures of human synovial cells for 6 weeks as cultivable organisms and thereafter for 2 more weeks as antigen aggregates containing specific lipopolysaccharides (LPS). Some seemingly intact bacteria were "ghosts," bacterial rods possessing LPS but not DNA. The prolonged persistence of yersiniae, and consequently of Yersinia antigens, in synovial cells may be the cause of the maintenance of the inflammatory host responses in the joints of patients with reactive arthritis due to Yersinia infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606125      PMCID: PMC173950          DOI: 10.1128/iai.64.4.1484-1487.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Yersinia in intestinal biopsy specimens from patients with seronegative spondyloarthropathy: correlation with specific serum IgA antibodies.

Authors:  J de Koning; J Heesemann; J A Hoogkamp-Korstanje; J J Festen; P M Houtman; P L van Oijen
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

2.  Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis.

Authors:  M Hammer; H Zeidler; S Klimsa; J Heesemann
Journal:  Arthritis Rheum       Date:  1990-12

3.  Application of the polymerase chain reaction and immunofluorescence techniques to the detection of bacteria in Yersinia-triggered reactive arthritis.

Authors:  A M Viitanen; T P Arstila; R Lahesmaa; K Granfors; M Skurnik; P Toivanen
Journal:  Arthritis Rheum       Date:  1991-01

4.  Ten-year follow-up study of patients with Yersinia arthritis.

Authors:  M Leirisalo-Repo; H Suoranta
Journal:  Arthritis Rheum       Date:  1988-04

5.  Double immunofluorescence microscopic technique for accurate differentiation of extracellularly and intracellularly located bacteria in cell culture.

Authors:  J Heesemann; R Laufs
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

6.  Triggering infections in reactive arthritis.

Authors:  V V Valtonen; M Leirisalo; P J Pentikäinen; T Räsänen; I Seppälä; U Larinkari; M Ranki; S Koskimies; M Malkamäki; P H Mäkelä
Journal:  Ann Rheum Dis       Date:  1985-06       Impact factor: 19.103

7.  Arthritogenicity of genetically manipulated Yersinia enterocolitica serotype O8 for Lewis rats.

Authors:  K I Gaede; J Heesemann
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

8.  How could infectious agents hide in synovial cells? Possible mechanisms of persistent viral infection in a model for the etiopathogenesis of chronic arthritis.

Authors:  H I Huppertz
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

9.  HeLa cell infection by Yersinia enterocolitica: evidence for lack of intracellular multiplication and development of a new procedure for quantitative expression of infectivity.

Authors:  J A Devenish; D A Schiemann
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

10.  Yersinia antigens in synovial-fluid cells from patients with reactive arthritis.

Authors:  K Granfors; S Jalkanen; R von Essen; R Lahesmaa-Rantala; O Isomäki; K Pekkola-Heino; R Merilahti-Palo; R Saario; H Isomäki; A Toivanen
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

View more
  10 in total

Review 1.  Reactive arthritis or chronic infectious arthritis?

Authors:  J Sibilia; F-X Limbach
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

2.  Lectin pathway factors in patients suffering from juvenile idiopathic arthritis.

Authors:  Katarzyna Kasperkiewicz; Łukasz Eppa; Anna S Świerzko; Marcin A Bartłomiejczyk; Zbigniew M Żuber; Katarzyna Siniewicz-Luzeńczyk; Elżbieta Mężyk; Misao Matsushita; Leokadia Bąk-Romaniszyn; Krzysztof Zeman; Mikael Skurnik; Maciej Cedzyński
Journal:  Immunol Cell Biol       Date:  2017-04-13       Impact factor: 5.126

3.  Expression of ICAM-1, ICAM-2, NCAM-1 and VCAM-1 by human synovial cells exposed to Borrelia burgdorferi in vitro.

Authors:  Sunit K Singh; Verena Baar; Henner Morbach; Hermann J Girschick
Journal:  Rheumatol Int       Date:  2005-11-24       Impact factor: 2.631

4.  Beta interferon is produced by Chlamydia trachomatis-infected fibroblast-like synoviocytes and inhibits gamma interferon-induced HLA-DR expression.

Authors:  J Rödel; A Groh; H Vogelsang; M Lehmann; M Hartmann; E Straube
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  Invasion and persistence of Salmonella in human fibroblasts positive or negative for endogenous HLA B27.

Authors:  H I Huppertz; J Heesemann
Journal:  Ann Rheum Dis       Date:  1997-11       Impact factor: 19.103

6.  [Advances in pediatric rheumatology. Experimental and clinical].

Authors:  H-I Huppertz
Journal:  Z Rheumatol       Date:  2016-04       Impact factor: 1.372

7.  Dendritic cell function is perturbed by Yersinia enterocolitica infection in vitro.

Authors:  M Schoppet; A Bubert; H I Huppertz
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

8.  Infection of synovial fibroblasts in culture by Yersinia enterocolitica and Salmonella enterica serovar Enteritidis: ultrastructural investigation with respect to the pathogenesis of reactive arthritis.

Authors:  A Meyer-Bahlburg; J Brinkhoff; V Krenn; K Trebesius; J Heesemann; H I Huppertz
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

9.  Development of rRNA-targeted PCR and in situ hybridization with fluorescently labelled oligonucleotides for detection of Yersinia species.

Authors:  K Trebesius; D Harmsen; A Rakin; J Schmelz; J Heesemann
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

Review 10.  A review of serological tests to assist diagnosis of reactive arthritis: critical appraisal on methodologies.

Authors:  Tamara Tuuminen; Kari Lounamo; Marjatta Leirisalo-Repo
Journal:  Front Immunol       Date:  2013-12-04       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.